Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Endocrine therapies for cancer significantly increase the risk of hair loss.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

More personalized and effective treatments for androgenetic alopecia are needed.

Testosterone is crucial for development, growth, and various body functions in mammals.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

New treatments using stem cells and other methods show promise for promoting hair growth in androgenetic alopecia.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Hirsutism is often caused by high male hormone levels and can be treated with lifestyle changes and medications.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Personalized treatments for hair loss are becoming more effective by using genetic information.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.